GLP-1 weight-loss drugs such as Ozempic and Wegovy are driving down grocery spending, according to a new study from Cornell’s ...

Eli Lilly has asked to join in opposing a lawsuit brought by compounding pharmacies against the U.S. Food and Drug ...

On its way out the door, the Biden administration is proposing that Medicare and Medicaid cover Ozempic and other GLP-1 drugs ...

These drugs, called glucagon-like peptide-1 receptor agonists (GLP-1 RAs), work in several different ways to help people lose ...

Obesity is more than a cosmetic concern. It’s a chronic disease that can be treated with drugs like semaglutide (Wegovy) and ...

Other viruses reared their heads as well in 2024: Puerto Rico, Los Angeles and the Florida Keys all reported spikes in dengue ...

It hasn’t been a smooth year for the two pharma giants, but events in the fourth quarter widened the gap between them.

For a long time, dieting and exercise were the only realistic options for many people who wanted to lose weight, but recent ...

Experts are urging anyone looking to shed a few pounds in the New Year to think twice before buying dangerous weight-loss ...

As 2024 draws to a close, the new year ushers in the opportunity to set new goals for the year ahead. While weight-loss and fitness are staples of New Year resolutions they are commonly known to be ...

Long NHS waiting lists could be fuelling a rise in people purchasing weight-loss jabs online, the nation’s top GP has warned.

While GLP-1 medications like Ozempic and Wegovy ... remain manageable Insurance coverage continues expanding New formulations ...